To a Carpenter, Every Problem Is a Nail - FDA Brings Hammer to Diagnostic Medicine

Learn about FDA regulatory approaches to diagnostic medicine through this invited speaker presentation delivered by Dara Aisner at the Cancer Genomics Consortium 2024 Annual Meeting. Explore the metaphorical concept of how regulatory frameworks may apply uniform solutions to diverse diagnostic challenges in clinical practice. Gain insights into the intersection of federal regulation and diagnostic medicine, examining how FDA oversight impacts clinical decision-making and diagnostic testing practices. Understand the implications of regulatory standardization on the field of diagnostic medicine and its effects on clinical laboratories and healthcare providers. Discover perspectives on balancing regulatory compliance with clinical flexibility in diagnostic testing environments.